tiprankstipranks
Trending News
More News >
BWX Technologies (BWXT)
NYSE:BWXT

BWX Technologies (BWXT) AI Stock Analysis

Compare
1,017 Followers

Top Page

BW

BWX Technologies

(NYSE:BWXT)

Rating:75Outperform
Price Target:
$158.00
▲(10.56%Upside)
BWX Technologies demonstrates robust financial performance and positive strategic outlook, highlighted by strong earnings call results. However, concerns about valuation and potential technical pullbacks temper the overall score. The company's position within the Aerospace & Defense industry remains solid, with opportunities for future growth.
Positive Factors
Defense Sector
BWXT's strategic focus on supporting the defense industrial base strengthens its position at a time when other suppliers face challenges.
Market Opportunities
The radiopharma business represents a significant opportunity for BWXT, with the potential to serve a $30 billion market.
Strategic Partnerships
BWXT has secured content wins with GE Vernova, Rolls-Royce, and TerraPower, indicating a strong position in the SMR market.
Negative Factors
Contract Uncertainty
There are no contracts in place yet for BWXT's involvement with the AP1000 and AP300, indicating uncertainty in this area.
Margin Expectations
BWXT maintained most 2025 guidance including revenue, EBITDA and FCF, but expects margins in the commercial operations business segment to be at the lower end of the 2025 guidance range.
Quarterly Performance Expectations
BWXT expects a q/q decline in revenue & EBITDA in 2Q25.

BWX Technologies (BWXT) vs. SPDR S&P 500 ETF (SPY)

BWX Technologies Business Overview & Revenue Model

Company DescriptionBWX Technologies, Inc. manufactures and sells nuclear components in the United States, Canada, and internationally. It operates in three segments: Nuclear Operations Group, Nuclear Power Group, and Nuclear Services Group. The Nuclear Operations Group segment provides precision naval and critical nuclear components, reactors, nuclear fuel, and assemblies for the United States Department of Energy/National Nuclear Security Administration's Naval Nuclear Propulsion Program and other uses; missile launch tubes for United States Navy submarines; close-tolerance and equipment for nuclear applications; and converts Cold War-era government stockpiles of high-enriched uranium, as well as receives, stores, characterizes, dissolves, recovers, and purifies uranium-bearing materials; supplies research reactor fuel elements for colleges, universities, and national laboratories; and components for defense applications. The Nuclear Power Group segment offers commercial nuclear steam generators, nuclear fuel, fuel handling systems, pressure vessels, reactor components, heat exchangers, tooling delivery systems, and containers; engineering and in-plant services for nuclear power plants; designs, manufactures, commissions, and services nuclear power generation equipment; in-plant inspection, maintenance, and modification services, as well as non-destructive examination and tooling/repair solutions; and supplies medical radioisotopes and radiopharmaceuticals for research, diagnostic, and therapeutic uses. The Nuclear Services Group segment provides nuclear materials processing, environmental site restoration, and management and operating services; develops technology for nuclear power sources application; and designs, engineers, licenses, and manufactures nuclear reactors. The company was formerly known as The Babcock & Wilcox Company and changed its name to BWX Technologies, Inc. in June 2015. BWX Technologies, Inc. was founded in 1867 and is headquartered in Lynchburg, Virginia.
How the Company Makes MoneyBWX Technologies makes money through several key revenue streams, primarily driven by government contracts and partnerships. The company is a major supplier of nuclear components and fuel for the U.S. Navy's nuclear-powered submarines and aircraft carriers, which constitutes a significant portion of its revenue. Additionally, BWXT generates income from the production and management of nuclear materials and facilities for various government and commercial clients. The company also capitalizes on its expertise in nuclear technology by providing engineering and technical services for government nuclear programs. Furthermore, BWXT is involved in the development and supply of medical isotopes, contributing to its revenue through sales in the healthcare sector.

BWX Technologies Earnings Call Summary

Earnings Call Date:May 05, 2025
(Q1-2025)
|
% Change Since: 27.88%|
Next Earnings Date:Aug 04, 2025
Earnings Call Sentiment Positive
The earnings call reflects a strong financial performance with significant growth in revenue, adjusted EBITDA, and strategic contract wins. Despite the challenges with raw material costs and delays in Tc-99 approval, the robust bookings, backlog, and strategic expansions in nuclear capabilities contribute to a positive outlook.
Q1-2025 Updates
Positive Updates
Strong Financial Performance
BWXT had a solid start in Q1 2025 with double-digit year-over-year revenue, adjusted EBITDA, and adjusted EPS growth. Revenue was $682 million, up 13%, and adjusted EPS was $0.91, up 20%.
Robust Bookings and Backlog
Commercial operations backlog reached $1.3 billion, up 78% year-over-year, driven by strong bookings in commercial power and nuclear medicine.
Strategic Contract Wins
BWXT won the management and operations contract for the Department of Energy's Strategic Petroleum Reserve and the NNSA's intent to award the Domestic Uranium Enrichment Centrifuge Experiment on a sole-source basis.
Expansion in Nuclear Capabilities
BWXT is expanding the Cambridge manufacturing plant by nearly 50% and progressing with the acquisition of Kinectrics, enhancing its nuclear services portfolio.
Government Operations Growth
Government operations had a strong quarter with 14% revenue growth and 17% adjusted EBITDA growth, driven by naval propulsion and special materials.
Advancements in Nuclear Medicine
BWXT Medical reported double-digit revenue and EBITDA growth, with expectations for full-year revenue growth of over 20%.
Negative Updates
Zirconium Cost Impact
BWXT faced heightened inflation for specialized raw materials in the CANDU Fuel business line, affecting margins. The impact is expected to persist through Q2 but will be mitigated in the second half of the year.
Challenges with Tc-99 Approval
BWXT is still working on perfecting the Tc-99 product for FDA approval, which may extend into early 2026, impacting the 2025 sales outlook.
Company Guidance
During BWX Technologies' first quarter 2025 earnings call, leadership highlighted several key metrics and achievements. The company reported double-digit year-over-year growth in revenue, adjusted EBITDA, and adjusted earnings per share. Specifically, government operations saw a 14% increase in revenue and a 17% rise in adjusted EBITDA, while commercial operations experienced a 10% revenue growth. The commercial operations backlog reached a record $1.3 billion, up 78% from the previous year. The adjusted effective tax rate for the first quarter was 18.3%, contributing to adjusted earnings per share of $0.91, up from $0.76 the previous year. Free cash flow for the quarter was $17 million, with capital expenditures at $33 million, or 4.9% of sales. The company reaffirmed its full-year guidance, expecting mid-single-digit revenue growth in government operations and a 50% increase in commercial operations revenue.

BWX Technologies Financial Statement Overview

Summary
BWX Technologies shows strong financial performance with solid revenue growth and profitability. The robust EBIT and net profit margins, alongside a strong cash flow situation, demonstrate efficient financial management. However, there is room for improvement in strengthening its equity position.
Income Statement
85
Very Positive
BWX Technologies demonstrates solid performance in terms of revenue growth and profitability. The Gross Profit Margin improved significantly from prior years, reaching 42.7% TTM, indicating effective cost management. The company also achieved a robust EBIT margin of 13.4% and a Net Profit Margin of 10.4% TTM. Additionally, revenue growth over the past year was approximately 2.9%, showing consistent upward trajectory, though the EBIT margin saw a slight decrease compared to previous periods.
Balance Sheet
78
Positive
The company's balance sheet reflects a stable financial position with a Debt-to-Equity Ratio of 1.09 TTM, suggesting moderate leverage. ROE stands at 26.3% TTM, indicating efficient use of equity to generate profits. The Equity Ratio of 36% TTM shows a balanced approach toward financing through debt and equity, although it remains on the lower side, which could imply potential risk if liabilities increase significantly.
Cash Flow
82
Very Positive
BWX Technologies shows a commendable cash flow situation with an Operating Cash Flow to Net Income Ratio of 1.47 TTM, highlighting strong cash generation capabilities. Free Cash Flow grew by 5.8% compared to the previous year, and the Free Cash Flow to Net Income Ratio of 0.93 TTM indicates efficient conversion of net income into free cash. Despite moderate capital expenditures, the company maintains a healthy cash flow position, supporting future growth prospects.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.78B2.70B2.50B2.23B2.12B2.12B
Gross Profit1.19B655.21M620.59M551.93M550.28M575.40M
EBITDA439.74M474.06M447.00M386.01M470.85M422.34M
Net Income289.00M281.94M245.85M238.19M305.87M278.67M
Balance Sheet
Total Assets3.05B2.87B2.75B2.62B2.50B2.29B
Cash, Cash Equivalents and Short-Term Investments55.44M74.11M78.62M39.05M37.70M46.32M
Total Debt1.20B1.06B1.21B1.29B1.19B951.42M
Total Liabilities1.95B1.79B1.81B1.87B1.86B1.68B
Stockholders Equity1.10B1.08B933.35M748.31M637.17M617.77M
Cash Flow
Free Cash Flow269.46M254.78M212.41M46.39M74.97M-58.59M
Operating Cash Flow426.05M408.43M363.70M244.70M386.03M196.44M
Investing Cash Flow-280.59M-154.56M-155.64M-256.24M-304.65M-265.32M
Financing Cash Flow-135.84M-252.78M-169.37M13.95M-90.14M25.05M

BWX Technologies Technical Analysis

Technical Analysis Sentiment
Positive
Last Price142.91
Price Trends
50DMA
123.33
Positive
100DMA
112.40
Positive
200DMA
115.23
Positive
Market Momentum
MACD
5.60
Positive
RSI
71.13
Negative
STOCH
51.47
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BWXT, the sentiment is Positive. The current price of 142.91 is above the 20-day moving average (MA) of 138.83, above the 50-day MA of 123.33, and above the 200-day MA of 115.23, indicating a bullish trend. The MACD of 5.60 indicates Positive momentum. The RSI at 71.13 is Negative, neither overbought nor oversold. The STOCH value of 51.47 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BWXT.

BWX Technologies Risk Analysis

BWX Technologies disclosed 29 risk factors in its most recent earnings report. BWX Technologies reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

BWX Technologies Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
DRDRS
78
Outperform
$12.35B53.239.50%0.78%13.58%25.96%
75
Outperform
$13.06B45.4428.24%0.70%9.87%14.16%
AIAIR
74
Outperform
$2.58B246.75-1.08%21.07%-120.95%
73
Outperform
$7.43B353.601.45%7.32%
HIHII
72
Outperform
$9.89B18.1712.27%2.14%-1.04%-21.80%
68
Neutral
$10.33B146.56
16.92%
65
Neutral
$10.77B15.805.51%1.90%3.03%-26.66%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
BWXT
BWX Technologies
142.91
48.26
50.99%
AIR
AAR
71.46
-0.89
-1.23%
HII
Huntington Ingalls
252.08
15.14
6.39%
KTOS
Kratos Defense
44.66
23.88
114.92%
DRS
Leonardo Drs
46.41
20.62
79.95%
SARO
StandardAero, Inc.
30.88
-2.09
-6.34%

BWX Technologies Corporate Events

Executive/Board ChangesBusiness Operations and Strategy
BWX Technologies Announces New Leadership Appointments
Positive
Jun 16, 2025

On June 16, 2025, BWX Technologies announced leadership changes with Kevin M. McCoy appointed as Chief Nuclear Officer to support the U.S. Navy’s submarine production, while Joseph K. Miller and Katherine Haggerty Kelly were promoted to key roles in Government Operations and Advanced Technologies, respectively. These appointments are expected to enhance BWXT’s capabilities in nuclear operations and advanced technology development, strengthening its position in the defense and energy sectors.

The most recent analyst rating on (BWXT) stock is a Buy with a $138.00 price target. To see the full list of analyst forecasts on BWX Technologies stock, see the BWXT Stock Forecast page.

Executive/Board ChangesBusiness Operations and Strategy
BWX Technologies Announces New Interim CFO Appointment
Neutral
May 12, 2025

On May 12, 2025, BWX Technologies announced the resignation of Robb A. LeMasters as CFO, with his decision unrelated to any company disagreements or financial issues. He will remain as a Special Advisor to the CEO until March 2026. Michael T. Fitzgerald, previously Vice President, Finance and Chief Accounting Officer, has been appointed as the interim CFO. Fitzgerald’s appointment is expected to support BWXT’s growth strategy and operational excellence, with his extensive corporate experience and financial understanding ensuring a smooth transition.

The most recent analyst rating on (BWXT) stock is a Buy with a $138.00 price target. To see the full list of analyst forecasts on BWX Technologies stock, see the BWXT Stock Forecast page.

Executive/Board Changes
BWX Technologies Grants CEO $5.5M Stock Incentive
Neutral
May 8, 2025

On May 7, 2025, BWX Technologies‘ Board of Directors approved a special grant of performance restricted stock units and non-qualified performance stock options to CEO Rex D. Geveden, valued at $5.5 million, to incentivize long-term shareholder value creation. The awards, which will vest on December 31, 2027, are contingent on achieving specific revenue, EBITDA margin, and shareholder return targets, reflecting the company’s commitment to aligning executive compensation with performance metrics.

Executive/Board ChangesShareholder MeetingsBusiness Operations and Strategy
BWX Technologies Shareholders Approve Key Governance Measures
Positive
May 7, 2025

At the Annual Meeting on May 2, 2025, BWX Technologies‘ stockholders voted on four key matters. The election of nine directors for a one-year term was approved, along with the advisory vote on executive compensation and the ratification of Deloitte & Touche LLP as the independent auditor. An amendment to limit officer liability under Delaware law also passed, indicating strong shareholder support for the company’s governance and operational strategies.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 19, 2025